Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
MrktWatch
 
about-us our-services Trading-account ETrade MF IPO Research Fundamentals charts Market Watch News

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Profit and Loss
Aarey Drugs & Pharmaceuticals Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs  Chairman  : Mihir R Ghatalia
    Home        : Indian Private  Book Value: 54.4604546
    BSE Code  : 524412  Market Cap: 328.46
    NSE Code  : AAREYDRUGS  P / E              : 78.66 

Change Company :
(Rs in Cr.)
Profit and Loss
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Sales Turnover & Other Income 483.75402.58421.69495.43355.43
Excise Duty0.000.000.000.000.00
Total Income494.55408.44436.83490.66356.89
Raw Materials 472.87387.76418.98461.35335.96
Stock Adjustments 10.805.8615.14-4.771.46
Other Manufacturing Expenses 1.960.761.507.154.99
Power & Fuel Cost0.050.030.030.040.00
Employee Cost 0.620.540.630.670.20
Selling and Administration Expenses 6.247.684.526.893.88
Miscellaneous Expenses 0.110.260.710.500.20
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Interest, Depreciation & Tax12.7011.4210.4514.0611.66
Interest & Financial Charges 4.664.382.872.042.44
Profit before Depreciation & Tax8.047.047.5812.029.22
Depreciation1.941.701.571.990.92
Profit Before Tax6.105.346.0110.038.30
Tax2.080.662.243.481.79
Profit After Tax4.024.683.776.556.51
Adjustment below Net Profit 0.000.000.00-0.010.00
P & L Balance brought forward53.1148.4244.6538.1131.59
Appropriations 0.000.000.000.000.00
P & L Bal. carried down57.1353.1148.4244.6538.11
Equity Dividend0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)0.000.000.000.000.00
Earning Per Share (Rs.)1.411.671.492.582.79
Book Value46.9045.5744.4343.8541.29
Extraordinary Items 0.000.000.000.000.00
Top
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   ODR Circular   |   Attention Investors   | Audit Compliance Report   | RA – Annual Compliance Audit Report 2024-25   | UPI IDs for Payment

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
Research Analyst SEBI Reg. No.INH000001527 | Research Analyst BSE Enlistment Number: 5104
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Designed, Developed, Maintained and Content Powered by
C-MOTS InfoTech(ISO 9001:2015 & ISO/IEC 27001:2022 Certified)
Charts are powered by TradingView